| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.002 | 0.9 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.0036 | 1 |